Edited by Peter Hillerberg1 min readStories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Rothschild & Co initiated coverage of both LMT and NOC at Buy on Tuesday, setting targets of $650 and $680 respectively. The dual initiation points to renewed institutional appetite for US defence names after months of budget uncertainty.
Bernstein added to the bullish pile on nuclear power. Analyst Sunaina Ocalan started CEG at Buy with a $296 target. The $95 billion nuclear operator carries short interest of just 3.4% of free float. ORTEX alternative data shows reactor output at peer VST running 10 standard deviations above its own history as of early September, reflecting surging grid demand that favours the whole nuclear fleet.
The sharpest single-stock call was a downgrade. BMO Capital's Daniel Jester cut PTC to Hold from Buy, slashing his target from $205 to $164. That is a 20% reduction. The industrial software firm carries SI of 5.3% of free float at a $21 billion market cap. A downgrade from a long-standing bull is typically the most credible signal of softening fundamentals.
Goldman Sachs lifted its target on connector maker APH to $116 from $102, maintaining Buy. Meanwhile, the consensus target on FICO slipped to $1,118 from $1,194, a reminder that even high-quality compounders face valuation pressure when rate expectations shift.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
